mitoXANTRONE
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6846 publications
XPO1 inhibitor selinexor suppresses homologous recombination by inhibiting E2F7 nuclear export in acute myeloid leukemia.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 24, 2026
Combination treatment with mitoxantrone and doxorubicin induces multidrug resistance in Ewing Sarcoma CDX reporter xenografts.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 17, 2026
Use of the MOF NU-1000 as a Drug Delivery System for the Antineoplastic Drug Mitoxantrone.
Journal: International journal of molecular sciences
Published: April 14, 2026
Vactosertib reverses ABCG2-mediated multidrug resistance through dual inhibition of drug efflux and transporter expression.
Journal: Experimental cell research
Published: April 07, 2026
Feline leukemia virus-negative acute lymphoid B-cell aleukemic leukemia in a cat with prolonged survival.
Journal: The Canadian veterinary journal = La revue veterinaire canadienne
Published: April 03, 2026
Correction: Phaeosphaeride A Isolated from an Endophytic Paraphoma sp. Alleviates ABCG2-mediated Resistance to Mitoxantrone in Breast Cancer Cells.
Journal: Planta medica
Published: March 12, 2026
Exploring Excited State Proton Transfer Dynamics upon Ultraviolet Excitation.
Journal: The journal of physical chemistry. A
Published: March 11, 2026
A multi-stage computational pipeline and in vitro validation for the discovery of small-molecule translation inhibitors targeting the bacterial ribosome.
Journal: RSC advances
Published: March 02, 2026
Circumvention of acquired resistance to topoisomerase II-targeted anticancer agents in HL-60 leukemia cells by prevention of intronic polyadenylation.
Journal: The Journal of pharmacology and experimental therapeutics
Published: February 20, 2026
(N)-Methanocarba Adenosine Derivatives as Dual Modulators of P-Glycoprotein and ABCG2 Transporters.
Journal: Journal of medicinal chemistry
Published: February 18, 2026
Outcomes of Myeloid Leukemia Associated With Down Syndrome Treated With a Reduced-Intensity Protocol: A Multicenter Experience in Argentina.
Journal: Pediatric blood & cancer
Published: February 17, 2026
Last Updated: 06/30/2026